Tacrolimus Ophthalmic Solution in Oil 0.02% compounded for dogs is prepared under a veterinarian’s prescription. This sterile, oil-based solution provides a lower-strength option for canine patients who require customized ophthalmic care. Veterinarians often choose this compounded preparation to support ocular comfort and tear production when suitable commercial alternatives are unavailable.
At Specialty Veterinary Pharmacy, we prepare every prescription using USP <797> sterile compounding standards. These guidelines help ensure consistency, sterility, and accuracy throughout the compounding process. As a result, pet owners and veterinarians can trust in the reliability of each order. Tacrolimus Ophthalmic Solution in Oil 0.02% comes in a 10 mL sterile ophthalmic bottle.
Specialty Veterinary Pharmacy compounds all sterile ophthalmic medications in a certified cleanroom inspected twice a year by an independent organization. These inspections confirm our full compliance with USP <797> standards.
In addition, each batch of Tacrolimus Ophthalmic Solution in Oil undergoes third-party laboratory testing with High-Performance Liquid Chromatography (HPLC) to confirm potency and sterility before release.
Therefore, veterinarians can depend on every bottle for consistent quality and verified accuracy. Test reports are available upon request for transparency.
MCT oil serves as a stable, odorless, and neutral carrier. It helps maintain even dispersion of the active ingredient and prevents separation. Moreover, the smooth oil base allows for gentle and consistent ocular application throughout the beyond-use period.
In addition, we maintain strict quality-control protocols from compounding to shipment, ensuring each prescription meets our rigorous internal standards.
By following these directions, you help preserve sterility and maintain the solution’s effectiveness during its 60-day beyond-use period.
In summary, Tacrolimus Ophthalmic Solution in Oil 0.02% is a sterile, lower-strength option for dogs that benefit from a precisely compounded ophthalmic formulation when commercial products are not appropriate.